The next generation of employee health is here. eMed is the leading platform for employer-sponsored preemptive health management, delivering personalized GLP-1 solutions.

We would like to show you a description here but the site won’t allow us.

eMed delivers a comprehensive program that provides eligible employees access to GLP-1 medications alongside ongoing clinical support. Designed to support adherence and long-term outcomes, this is …

Studies show GLP-1s can help people lose 15–20% of their body weight and improve blood sugar and heart health. But what really matters is how you take it – consistency, adherence, side-effect …

Effective January 1, 2026 for Fee-for-Service (FFS), and March 1, 2026 for Managed Care, preventative maintenance will be covered for all primary power wheelchairs (PWC) that are less than 5 years old. …

We empower patients with innovative home and subcutaneous infusion solutions, enhancing independence, treatment adherence, and quality of care. Designed for biologics and specialty drugs, …

Find the latest Electromedical Technologies, Inc. (EMED) stock quote, history, news and other vital information to help you with your stock trading and investing.

Stay connected with us and empower your team to achieve more!

Feb 27, 2026 · Get the latest Electromedical Technologies, Inc. (EMED) stock price quote with financials, statistics, dividends, charts, historical data and more.

In 1991, EMED was founded with a mission to revolutionize subcutaneous drug delivery through advanced infusion technology. By combining precision engineering with cutting-edge automation, we …